z-logo
Premium
Role of CYP4A/20‐HETE Pathway in Vascular Oxidative Stress in the Dahl Salt‐Sensitive Rat
Author(s) -
Lukaszewicz Kathleen,
Falck John,
Lombard Julian
Publication year - 2012
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.26.1_supplement.853.23
Subject(s) - oxidative stress , medicine , endocrinology , superoxide , superoxide dismutase , chemistry , endothelial dysfunction , pathogenesis , biology , biochemistry , enzyme
We tested the hypothesis that cytochrome P450‐4A (CYP4A) and 20‐hydroxyeicosatetraenoic acid (20‐HETE) contribute to vascular oxidant stress and endothelial dysfunction in Dahl salt‐sensitive (SS) rats. Endothelial dysfunction in SS rats was ameliorated by a CYP4A inhibitor (DDMS) or a 20‐HETE antagonist (20‐HEDE), and in SS‐5 BN consomic rats carrying CYP4A genes from the Brown Norway rat on the SS genetic background. Superoxide (SOX) levels, assessed via DHE fluorescence, were significantly higher in cerebral arteries of SS rats vs. SS‐5 BN rats fed either normal salt (NS, 0.4% NaCl) or high salt (HS, 4.0% NaCl) diet. DDMS reduced SOX in arteries of HS‐fed SS rats to the same degree as a superoxide scavenger (PEG‐SOD), suggesting that the CYP4A/20‐HETE system contributes to elevated vascular SOX in HS‐fed SS rats. CYP4A protein expression was significantly higher in cerebral arteries of SS rats fed NS or HS diet vs. SS‐5 BN rats. CuZn SOD, MnSOD, and EC‐SOD expression was similar in SS vs. SS‐5 BN , indicating that the elevated vascular SOX in SS vs. SS‐5 BN rats is not due to differences in antioxidant defenses. Treatment with the superoxide scavenger tempol had no effect on CYP4A expression in either strain. These findings indicate that increased expression/activity of the CYP4A/20‐HETE system contributes to vascular oxidant stress and endothelial dysfunction in SS rats fed either NS or HS diet. [NIH #HL65289, HL72920, HL92026, and AHA].

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here